文献速递心脑血管急症儿科与产科急症重症综合管理与镇静镇痛

氯胺酮对重型颅脑损伤患儿颅内压的急性效应

Acute Effects of Ketamine on Intracranial Pressure in Children With Severe Traumatic Brain Injury.
PubMed 文献 · Crit Care Med · 2023-02-21
一句话结论回顾性研究显示,在指南方案下,氯胺酮用于颅内压危象时颅内压下降、阈值校正脑灌注压升高,镇静剂量时颅内压与脑灌注压无显著变化。

该回顾性观察研究在30张床位的三级儿童医院PICU开展,纳入33例接受颅内压监测的重型颅脑损伤患儿(1月龄至16岁),其中22例接受氯胺酮单次推注,共分析127剂。仅用于镇静的氯胺酮剂量后,颅内压与脑灌注压较基线无显著差异;11例患儿在颅内压危象(颅内压>20 mm Hg持续>5 min)期间接受18剂氯胺酮,给药后颅内压下降、阈值校正脑灌注压升高。作者认为,若这些发现能在更大规模研究中重现,氯胺酮可能值得考虑用于治疗重型颅脑损伤患儿的颅内高压。

要点

  • 在指南方案下,颅内压危象(颅内压>20 mm Hg持续>5 min)期间给予18剂氯胺酮后,颅内压下降且阈值校正脑灌注压升高。
  • 仅用于镇静的氯胺酮剂量后,颅内压与脑灌注压较基线无显著差异。
  • 研究纳入33例重型颅脑损伤患儿(1月龄至16岁),22例接受氯胺酮单次推注,共分析127剂。
  • 接受与未接受氯胺酮推注的患者在人口学、患者及损伤特征方面相似。
  • 作者认为,若这些发现能在更大规模研究中重现,氯胺酮可能值得考虑用于治疗重型颅脑损伤患儿的颅内高压。

适用人群与场景

  • 接受颅内压监测的重型颅脑损伤患儿,年龄1月龄至16岁,来自30张床位的三级儿童医院PICU。

诊断标准与关键阈值

  • 颅内压危象定义为颅内压>20 mm Hg持续>5 min。
  • 采用基于年龄的脑灌注压阈值,从脑灌注压记录中减去该阈值后与基线值比较。

处置流程与药物剂量

  • 氯胺酮以单次推注给药,用于镇静或作为颅内压危象的治疗。

研究设计与关键结果

  • 回顾性观察研究,纳入33例重型颅脑损伤患儿,22例接受氯胺酮单次推注,共分析127剂。
  • 仅用于镇静的氯胺酮剂量后,颅内压与脑灌注压较基线无显著差异。
  • 11例患儿在颅内压危象期间接受18剂氯胺酮,给药后颅内压下降、阈值校正脑灌注压升高。
  • 接受与未接受氯胺酮推注的患者在人口学、患者及损伤特征方面相似。

证据类型、等级与局限

  • 证据类型:回顾性观察研究(探索性)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,若这些发现能在更大规模研究中重现,氯胺酮可能值得考虑用于治疗重型颅脑损伤患儿的颅内高压。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: The acute cerebral physiologic effects of ketamine in children have been incompletely described. We assessed the acute effects of ketamine on intracranial pressure (ICP) and cerebral perfusion pressure (CPP) in children with severe traumatic brain injury (TBI).

DESIGN: In this retrospective observational study, patients received bolus doses of ketamine for sedation or as a treatment for ICP crisis (ICP > 20 mm Hg for > 5 min). Administration times were synchronized with ICP and CPP recordings at 1-minute intervals logged in an automated database within the electronic health record. ICP and CPP were each averaged in epochs following drug administration and compared with baseline values. Age-based CPP thresholds were subtracted from CPP recordings and compared with baseline values. Trends in ICP and CPP over time were assessed using generalized least squares regression.

SETTING: A 30-bed tertiary care children's hospital PICU.

PATIENTS: Children with severe TBI who underwent ICP monitoring.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: We analyzed data from 33 patients, ages 1 month to 16 years, 22 of whom received bolus doses of ketamine, with 127 doses analyzed. Demographics, patient, and injury characteristics were similar between patients who did versus did not receive ketamine boluses. In analysis of the subset of ketamine doses used only for sedation, there was no significant difference in ICP or CPP from baseline. Eighteen ketamine doses were given during ICP crises in 11 patients. ICP decreased following these doses and threshold-subtracted CPP rose.

CONCLUSIONS: In this retrospective, exploratory study, ICP did not increase following ketamine administration. In the setting of a guidelines-based protocol, ketamine was associated with a reduction in ICP during ICP crises. If these findings are reproduced in a larger study, ketamine may warrant consideration as a treatment for intracranial hypertension in children with severe TBI.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Laws JC, Vance EH, Betters KA, et al. Acute Effects of Ketamine on Intracranial Pressure in Children With Severe Traumatic Brain Injury. Crit Care Med. 2023. PMID: 36825892. doi:10.1097/CCM.0000000000005806

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。